Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.93 - $18.45 $1.18 Million - $1.68 Million
91,000 New
91,000 $1.31 Million
Q3 2023

Nov 14, 2023

BUY
$9.81 - $12.62 $613,527 - $789,267
62,541 New
62,541 $702,000
Q4 2022

Feb 14, 2023

BUY
$11.49 - $13.65 $559,563 - $664,755
48,700 New
48,700 $595,000
Q2 2022

Aug 15, 2022

BUY
$19.63 - $26.62 $424,008 - $574,992
21,600 New
21,600 $424,000
Q1 2022

May 16, 2022

SELL
$24.65 - $29.0 $712,385 - $838,100
-28,900 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$27.74 - $34.09 $104,801 - $128,792
3,778 Added 15.04%
28,900 $820,000
Q3 2021

Nov 15, 2021

BUY
$29.2 - $36.72 $733,562 - $922,479
25,122 New
25,122 $801,000
Q2 2021

Aug 13, 2021

SELL
$28.76 - $35.98 $1.04 Million - $1.29 Million
-35,989 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$27.85 - $34.49 $1 Million - $1.24 Million
35,989 New
35,989 $1.06 Million
Q4 2019

Feb 14, 2020

SELL
$25.29 - $29.45 $347,636 - $404,819
-13,746 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$25.62 - $34.96 $352,172 - $480,560
13,746 New
13,746 $366,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.42B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.